#1 Clinical Trials Search in Europe

Dipyridamole

This article explores the use of dipyridamole, also known by brand names like Persantine and Permole, in various clinical trials. Dipyridamole is being studied for its potential benefits in conditions such as HIV, cardiovascular diseases, and even schizophrenia. The drug works by increasing adenosine levels in the body, which may have protective effects against ischemia-reperfusion injury and inflammation. Through these trials, researchers aim to better understand dipyridamole’s mechanisms of action and its potential to improve patient outcomes in different medical scenarios.

Table of Contents

Introduction

Dipyridamole is a medication that has been used for various cardiovascular conditions. It is also known by the brand names Persantine® and Permole®[2]. This article will provide an overview of dipyridamole, its uses, how it works, and current research being conducted with this drug.

Medical Uses

Dipyridamole is primarily used for the following conditions:

  • Prevention of blood clots: It is used with other drugs to reduce the risk of blood clots after heart valve replacement[2].
  • Coronary artery disease: It may be used in patients with coronary artery disease, a condition where the arteries supplying blood to the heart become narrowed or blocked[4].
  • Stress tests: Dipyridamole is sometimes used during cardiac stress tests to evaluate heart function[4].

How It Works

Dipyridamole works in several ways:

  • It increases the levels of a substance called adenosine in the body. Adenosine helps to widen blood vessels and improve blood flow[3].
  • It prevents platelets (small blood cells involved in clotting) from sticking together, which helps to prevent blood clots[2].
  • It may have anti-inflammatory effects and could potentially protect against damage caused when blood flow is restored to tissues after a period without oxygen (known as ischemia-reperfusion injury)[3].

Administration

Dipyridamole can be administered in different ways:

  • Oral tablets: Often given as 200mg twice daily[3].
  • Intravenous (IV) injection: Used in certain medical procedures or tests[4].

The specific dosage and method of administration will depend on the condition being treated and will be determined by a healthcare provider.

Current Research

Several clinical trials are exploring new potential uses for dipyridamole:

  • HIV treatment: Researchers are studying whether dipyridamole can reduce inflammation in HIV-infected individuals who are already on antiretroviral treatment[2].
  • Heart surgery: Studies are investigating if dipyridamole can protect the heart from damage during coronary artery bypass grafting (CABG) surgery[5].
  • Ischemia-reperfusion injury: Research is being conducted to see if dipyridamole can protect against damage caused when blood flow returns to tissues after a period without oxygen[3].

Potential Side Effects

Like all medications, dipyridamole can cause side effects. Some potential side effects include:

  • Headache, especially during the first few days of treatment[3]
  • Dizziness
  • Nausea
  • Flushing (redness of the skin)

It’s important to discuss any side effects with your healthcare provider.

Frequently Asked Questions

What is dipyridamole used for?

Dipyridamole is primarily used to prevent blood clots, especially in patients who have had heart valve replacement. It’s also used in some heart tests and is being studied for potential use in other conditions like HIV and protecting the heart during surgery.

How does dipyridamole work?

Dipyridamole works by increasing levels of a substance called adenosine in the body, which helps widen blood vessels and improve blood flow. It also prevents platelets from sticking together, which helps prevent blood clots.

Are there any side effects of dipyridamole?

Common side effects can include headache, especially when first starting the medication, as well as dizziness, nausea, and flushing. Always discuss any side effects with your healthcare provider.

Summary

Aspect Details
Primary Uses Prevent blood clots, used in coronary artery disease
How It Works Increases adenosine levels, prevents platelet aggregation
Administration Oral tablets or intravenous injection
Current Research HIV treatment, heart surgery protection, ischemia-reperfusion injury
Common Side Effects Headache, dizziness, nausea, flushing

Glossary

  • Adenosine – A naturally occurring substance in the body that helps regulate blood flow and heart function
  • Antiretroviral treatment – Medications used to treat HIV infection
  • Coronary artery bypass grafting (CABG) – A type of heart surgery used to improve blood flow to the heart
  • Ischemia-reperfusion injury – Damage that occurs when blood supply returns to tissue after a period of lack of oxygen
  • Platelets – Small blood cells that help form clots to stop bleeding

Trial Sources

  • [1]: https://clinicaltrials.gov/study/NCT00002487
  • [2]: https://clinicaltrials.gov/study/NCT02121756
  • [3]: https://clinicaltrials.gov/study/NCT00457405
  • [4]: https://clinicaltrials.gov/study/NCT00763009
  • [5]: https://clinicaltrials.gov/study/NCT01295567
Aspect Details
Main Uses in Trials HIV-related inflammation, cardiovascular protection, ischemia-reperfusion injury prevention, schizophrenia symptoms
Mechanism of Action Increases adenosine levels by inhibiting nucleoside transporters
Administration Methods Oral tablets (e.g., 200mg twice daily), intravenous injection
Common Outcome Measures Biomarkers of inflammation, heart damage indicators (e.g., troponin), coronary blood flow, psychiatric symptom scales
Potential Side Effects Headache, dizziness, gastrointestinal symptoms, changes in blood pressure or heart rhythm
Notable Trial Designs Placebo-controlled, crossover studies, combination with other drugs (e.g., adenosine)
Patient Populations HIV patients, cardiovascular disease patients, healthy volunteers, schizophrenia patients

FAQ

  • What is dipyridamole and how does it work? Dipyridamole is a medication that increases adenosine levels in the body by inhibiting nucleoside transporters. It's known by brand names like Persantine and Permole. This mechanism may help protect against ischemia-reperfusion injury and reduce inflammation, which is why it's being studied in various medical conditions.
  • In which medical conditions is dipyridamole being studied? Clinical trials are exploring dipyridamole's potential in several conditions, including HIV infection, cardiovascular diseases (such as coronary artery disease and ischemia-reperfusion injury), and even schizophrenia. It's being investigated for its ability to reduce inflammation, protect against heart damage, and potentially improve symptoms in these diverse conditions.
  • How is dipyridamole administered in these clinical trials? The administration of dipyridamole varies across trials. Some studies use oral tablets (e.g., 200mg twice daily), while others use intravenous administration. The dosage and duration of treatment also differ depending on the specific trial and condition being studied.
  • What are some potential side effects of dipyridamole? Common side effects of dipyridamole may include headache, dizziness, and gastrointestinal symptoms. In some trials, researchers are specifically monitoring for adverse events such as chest pain, shortness of breath, changes in blood pressure, and heart rhythm disturbances. It's important to note that side effects can vary depending on the dosage and individual patient factors.
  • How do researchers measure the effectiveness of dipyridamole in these trials? Researchers use various methods to assess dipyridamole's effectiveness, depending on the condition being studied. These may include measuring biomarkers of inflammation or heart damage (like troponin levels), assessing changes in coronary blood flow, evaluating symptoms in psychiatric conditions, or looking at long-term outcomes such as cardiovascular events or mortality rates.

Ongoing Clinical Trials on Dipyridamole

  • Study on Managing Risk Factors in Patients with Unruptured Brain Aneurysms Using Carbasalate Calcium and Intensive Blood Pressure Treatment

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland Germany The Netherlands

  • Study on Stopping or Continuing Clopidogrel, Carbasalate Calcium, and Dipyridamole for Young Patients After Stroke Without a Known Cause

    Recruiting

    3 1 1 1
    Investigated drugs:
    The Netherlands

  • Study on the Effects of Adenosine, Dipyridamole, and Apixaban in Patients with Takotsubo Syndrome

    Recruiting

    3 1 1 1
    Investigated drugs:
    Denmark Norway Sweden

Glossary

  • Adenosine: A naturally occurring compound in the body that plays important roles in energy transfer and signal transduction. Dipyridamole works by increasing adenosine levels.
  • Ischemia-reperfusion injury: Tissue damage caused when blood supply returns to tissue after a period of lack of oxygen. Dipyridamole is being studied for its potential to reduce this type of injury.
  • Coronary artery bypass grafting (CABG): A type of heart surgery used to improve blood flow to the heart in patients with severe coronary artery disease.
  • Troponin: A protein released into the blood when heart muscle has been damaged. It's often measured to assess the extent of heart injury.
  • Percutaneous coronary intervention (PCI): A non-surgical procedure used to treat narrowed coronary arteries, often referred to as angioplasty with stent.
  • Biomarker: A measurable indicator of a biological state or condition. In these trials, various biomarkers are used to assess inflammation, heart damage, or drug effectiveness.
  • Placebo: An inactive substance used in clinical trials to compare the effects of a drug against no treatment.
  • Annexin A5: A protein used in some studies to measure cell death, which can indicate the extent of tissue damage.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Double-blind study: A type of clinical trial where neither the participants nor the researchers know who is receiving the actual treatment and who is receiving a placebo.